Novo-Nordisk, DK0062498333

Novo Nordisk stock slips 0.49% to EUR 36.63 before Xetra

Published on 11/18/2026 at 07:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
The Danish drugmaker develops and sells prescription medicines. On Xetra, the stock closed at EUR 36.81 on Tuesday, November 17, 2026.

Key points for investors

  • Novo Nordisk is a Danish pharmaceutical company focused on prescription medicines.
  • The company develops treatments for approved indications across multiple disease areas.
Novo-Nordisk, DK0062498333, Illustration mit AI erstellt.

Novo Nordisk stock traded at EUR 36.63 on Lang & Schwarz at 07:51 CET on Wednesday, November 18, 2026, 0.49 percent below the Xetra close of Tuesday, November 17, at EUR 36.81.

The Danish pharmaceutical company develops and sells prescription medicines for approved indications across multiple disease areas.

European equities trade in the broader Euro Stoxx 50 market context.

More news and analyses on Novo Nordisk stock

Disclaimer...
en | DK0062498333 | NOVO-NORDISK | boerse | 70529803 | bgmi